JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation
Allist Pharmaceuticals, Inc.
Allist Pharmaceuticals, Inc.
Cybrexa Therapeutics
Revolution Medicines, Inc.
INSYS Therapeutics Inc
Delcath Systems Inc.